Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Modality Therapy With Growth Factor Support for Patients With Limited Stage Small Cell Lung Cancer
NCT00554463Phase 2Completed
- Sponsor
- NRG Oncology
- Start
- Jan 2008
- Primary completion
- Aug 2011
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of filgrastim, pegfilgrastim in neutropenia, febrile neutropenia (FN), sponsored by NRG Oncology. Started Jan 2008; status: completed.
02
Drugs
filgrastimpegfilgrastim
03
Conditions
neutropeniafebrile neutropenia (FN)
Beyond the preview
Go deeper on NCT00554463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00554463.